Ranibizumab ophthalmic and Zohydro ER Capsules
Determining the interaction of Ranibizumab ophthalmic and Zohydro ER Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: Hydrocodone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab ophthalmic-Zoladex
- Ranibizumab ophthalmic-Zoladex (Goserelin Implant 10.8 mg)
- Ranibizumab ophthalmic-Zoladex (Goserelin Implant 3.6 mg)
- Ranibizumab ophthalmic-Zoladex 3-Month
- Ranibizumab ophthalmic-Zoladex Implant
- Ranibizumab ophthalmic-Zolate
- Zohydro ER Capsules-Ranitidine
- Zohydro ER Capsules-Ranitidine Capsule
- Zohydro ER Capsules-Ranitidine Hydrochloride
- Zohydro ER Capsules-Ranitidine Injection
- Zohydro ER Capsules-Ranitidine Suspension
- Zohydro ER Capsules-Ranitidine Syrup